CH639941A5 - Polypeptides, process for their preparation and their use - Google Patents

Polypeptides, process for their preparation and their use Download PDF

Info

Publication number
CH639941A5
CH639941A5 CH206278A CH206278A CH639941A5 CH 639941 A5 CH639941 A5 CH 639941A5 CH 206278 A CH206278 A CH 206278A CH 206278 A CH206278 A CH 206278A CH 639941 A5 CH639941 A5 CH 639941A5
Authority
CH
Switzerland
Prior art keywords
val
gln
polypeptide according
tyr
radical
Prior art date
Application number
CH206278A
Other languages
German (de)
English (en)
Inventor
Gideon Goldstein
David H Schlesinger
Original Assignee
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Inst Cancer filed Critical Sloan Kettering Inst Cancer
Publication of CH639941A5 publication Critical patent/CH639941A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CH206278A 1977-11-15 1978-02-24 Polypeptides, process for their preparation and their use CH639941A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85177777A 1977-11-15 1977-11-15

Publications (1)

Publication Number Publication Date
CH639941A5 true CH639941A5 (en) 1983-12-15

Family

ID=25311654

Family Applications (1)

Application Number Title Priority Date Filing Date
CH206278A CH639941A5 (en) 1977-11-15 1978-02-24 Polypeptides, process for their preparation and their use

Country Status (7)

Country Link
JP (2) JPS5476543A (sv)
BE (1) BE864121A (sv)
CA (1) CA1105925A (sv)
CH (1) CH639941A5 (sv)
DE (1) DE2804566C2 (sv)
FR (1) FR2408580A1 (sv)
SE (1) SE446867B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods
US4215111A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Peptides having ubiquitin-like activity
JPS55149237A (en) * 1979-04-12 1980-11-20 Ortho Pharma Corp Thymopoietin active peptide
DE2938420A1 (de) * 1979-09-22 1981-04-09 Hoechst Ag, 6000 Frankfurt Neue peptide und verfahren zu ihrer herstellung
US4426324A (en) * 1979-09-28 1984-01-17 Hoffmann-La Roche Inc. Immunopotentiating peptides
US4298523A (en) * 1980-06-17 1981-11-03 Ortho Pharmaceutical Corporation Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R
DE3401545A1 (de) * 1983-08-03 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue peptide mit immunstimulierender wirkung, verfahren zu deren herstellung und deren verwendung
US4629723A (en) * 1984-06-27 1986-12-16 Ortho Pharmaceutical Corporation Potent thymopentin analogs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002740A (en) * 1975-08-21 1977-01-11 Gideon Goldstein Tridecapeptide compositions and methods

Also Published As

Publication number Publication date
FR2408580A1 (fr) 1979-06-08
BE864121A (fr) 1978-08-21
SE446867B (sv) 1986-10-13
JPS5476543A (en) 1979-06-19
DE2804566A1 (de) 1979-05-17
JPS6118560B2 (sv) 1986-05-13
CA1105925A (en) 1981-07-28
DE2804566C2 (de) 1986-01-16
JPH0137399B2 (sv) 1989-08-07
SE7801030L (sv) 1979-05-16
JPS6150998A (ja) 1986-03-13
FR2408580B1 (sv) 1983-01-07

Similar Documents

Publication Publication Date Title
EP0028627B1 (de) Verfahren zur herstellung von thymosin-alpha1 und derivaten davon
US4190646A (en) Polypeptide compositions and methods
EP0067425A1 (de) Gegebenenfalls geschützte Peptide, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CH639361A5 (de) Peptide, verfahren zu deren herstellung und pharmazeutische praeparate, welche diese als wirkstoff enthalten.
DE3100974A1 (de) Thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente enthaltende arzneimittel mit immunregulierender wirkung, und thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente
DE2256445A1 (de) Neue heptapeptide mit gastrinwirkung
DE2822951A1 (de) Neue polypeptide mit thymusaktivitaet oder antagonistischer aktivitaet und verfahren zu ihrer herstellung
DE60133654T2 (de) Arzneimittel enthaltend analgetische peptide
CH639941A5 (en) Polypeptides, process for their preparation and their use
CH615904A5 (en) Process for the preparation of L-leucine-13-motilin
JPH0153268B2 (sv)
EP0135722B1 (de) Neue Peptide mit immunstimulierender Wirkung, Verfahren zu deren Herstellung und deren Verwendung
DE2804567C2 (de) Pentapeptide, Verfahren zu ihrer Herstellung und ihre Verwendung
CH642058A5 (de) Polypeptide sowie diese polypeptide enthaltende arzneimittel.
EP0033384B1 (de) Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunstimulierender Wirkung, und Thymosin-alpha-1-Fragmente
DE2718718A1 (de) Somatostatinanaloge und zwischenprodukte hierzu
EP0338437A2 (de) Synthetische Vakzine gegen die Maul- und Klauenseuche und Verfahren zu deren Herstellung
EP0080194B1 (de) Neue Peptide und Verfahren zu ihrer Herstellung
DE2628006C2 (de) Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung
CH645880A5 (de) Synthetisches antigenaktives polypeptid, verfahren zu dessen herstellung und das polypeptid enthaltendes antigenes mittel sowie arzneimittel.
EP0095557B1 (de) Polypeptide mit antagonistischen Eigenschaften gegenüber der Substanz P, Verfahren zu ihrer Herstellung, deren Verwendung und Verfahren zum Reinigen von Polypeptiden
CH654841A5 (de) Appetitzuegelnde tripeptide und verfahren zur herstellung derselben.
DE3333752A1 (de) Pharmakologisch aktive peptide
US4258152A (en) Pentapeptide modified resin
AT384812B (de) Verfahren zur herstellung neuer polypeptide

Legal Events

Date Code Title Description
PL Patent ceased